Home > Boards > US Listed > Biotechs > Co-Diagnostics Inc. (CODX)

Calm down longs. Presenting what you have at

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
turning stone Member Profile
Followed By 14
Posts 678
Boards Moderated 0
Alias Born 03/24/09
160x600 placeholder
Co-Diagnostics, Inc. to Present at COVID-19 Virtual Conference Hosted by Maxim Group on May 27, 2020 PR Newswire (US) - 5/27/2020 6:30:00 AM
Co-Diagnostics, Inc. COVID-19 Test Successfully Used to Identify Coronavirus in Cancer Tissue PR Newswire (US) - 5/26/2020 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 9:15:30 AM
Co-Diagnostics, Inc. Releases Prepared Remarks for First Quarter 2020 Conference Call PR Newswire (US) - 5/14/2020 6:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 4:07:59 PM
Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter Update PR Newswire (US) - 5/14/2020 4:01:00 PM
Co-Diagnostics, Inc. Announces Q1 2020 Earnings Release Date and Earnings Call PR Newswire (US) - 5/12/2020 4:40:00 PM
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits PR Newswire (US) - 5/4/2020 6:30:00 AM
Co-Diagnostics, Inc. Announces Expansion of COVID-19 Test Orders in the United States PR Newswire (US) - 4/20/2020 6:30:00 AM
Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples PR Newswire (US) - 4/16/2020 6:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/15/2020 11:47:43 AM
Co-Diagnostics, Inc. Contracts with Promega Corp for COVID-19 Test Manufacturing as Company Expands Domestic Customer Base PR Newswire (US) - 4/14/2020 6:30:00 AM
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test PR Newswire (US) - 4/6/2020 6:30:00 AM
Co-Diagnostics, Inc. Reports 2019 Year-End Financial Results and Progress Updates Business Wire - 3/31/2020 10:02:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/30/2020 5:31:54 PM
Co-Diagnostics (NASDAQ:CODX) Reiterated Buy; Joins Distinguished Group Racing to Meet Unprecedented Global Demand for COVID-1... GlobeNewswire Inc. - 3/25/2020 11:30:10 AM
PreCheck Begins Filling Orders for Coronavirus (COVID-19) PCR Test and Announces Distribution Agreements in Romania and Moldo... GlobeNewswire Inc. - 3/20/2020 8:00:10 AM
Co-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use Authorization Business Wire - 3/20/2020 6:30:00 AM
Co-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 Diagnostic Business Wire - 3/19/2020 6:30:00 AM
FDA Policy Change to Allow Rapid Domestic Expansion of Co-Diagnostics COVID-19 Test Business Wire - 3/17/2020 6:30:00 AM
PreCheck Health to Exclusively Distribute Coronavirus COVID-19 Test in Ecuador, a Population of 16 Million, for Co-Diagnostic... Business Wire - 3/13/2020 8:00:00 AM
Co-Diagnostics, Inc Chief Scientific Officer to Address Bipartisan Commission on Biodefense in Washington, D.C. Business Wire - 3/12/2020 6:30:00 AM
Buy for Co-Diagnostics (NASDAQ:CODX) Reiterated by H.C. Wainwright with $20 Price Target GlobeNewswire Inc. - 3/11/2020 9:30:10 AM
Co-Diagnostics (NASDAQ:CODX) Ready to Meet U.S Vice President’s Plea for More Domestic Tests GlobeNewswire Inc. - 3/6/2020 1:01:26 PM
Co-Diagnostics, Inc. Reports Additional Demand for Coronavirus Test Shipments Business Wire - 3/5/2020 6:30:00 AM
turning stone   Thursday, 02/13/20 09:40:16 AM
Re: None
Post # of 2860 
Calm down longs. Presenting what you have at a conference is important as it gets you out in front of important people but it does not usually move the share price. It does tell us that they have what they say they have which is always good. Now we need the FDA to act.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist